Skip to main content
Erschienen in: Clinical & Experimental Metastasis 5-6/2018

23.07.2018 | Commentary

Future perspectives: cancer metastases

verfasst von: Stanley P. Leong, Jonathan S. Zager

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 5-6/2018

Einloggen, um Zugang zu erhalten

Abstract

The sentinel lymph node (SLN) is the initial metastatic site for the majority of solid cancers. In some cases, cancer cells may bypass the SLNs and enter the vascular channels directly to spread to the systemic sites. Metastatic progression is an orderly process. During the process of metastasis, complex biochemical and molecular mechanisms are involved being subjected to the host influence, in particular, the immune system. With more detailed understanding of the genomic and molecular characteristics of cancer both from the primary site and its metastases, the pathways of cancer growth and spread within the cancer microenvironment may be further elucidated.
Literatur
1.
Zurück zum Zitat Mamam S, Witz IP. Perspectives (2018) A history of exploring cancer in context. Nat Rev Cancer 18(6):359–376CrossRef Mamam S, Witz IP. Perspectives (2018) A history of exploring cancer in context. Nat Rev Cancer 18(6):359–376CrossRef
3.
Zurück zum Zitat Reintgen D, Cruse CW, Wells K et al (1994) The orderly progression of melanoma nodal metastases. Ann Surg 220(6):759–767CrossRef Reintgen D, Cruse CW, Wells K et al (1994) The orderly progression of melanoma nodal metastases. Ann Surg 220(6):759–767CrossRef
5.
Zurück zum Zitat Rios-Cantu A, Lu Y, Melendez-Elizondo V et al (2017) Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin? Clin Exp Metastasis 34:345–350CrossRef Rios-Cantu A, Lu Y, Melendez-Elizondo V et al (2017) Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin? Clin Exp Metastasis 34:345–350CrossRef
6.
Zurück zum Zitat Leung AM, Morton DL, Ozao-Choy J et al (2013) Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system. JAMA Surg 148:879–884CrossRef Leung AM, Morton DL, Ozao-Choy J et al (2013) Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system. JAMA Surg 148:879–884CrossRef
7.
Zurück zum Zitat Thomas DC, Han G, Leong SP et al (2017) Predictors for melanoma recurrence and the impact of recurrence type on outcomes after a negative sentinel lymph node biopsy. Society of Surgical Oncology Annual Meeting 2017, Poster presentation Thomas DC, Han G, Leong SP et al (2017) Predictors for melanoma recurrence and the impact of recurrence type on outcomes after a negative sentinel lymph node biopsy. Society of Surgical Oncology Annual Meeting 2017, Poster presentation
8.
Zurück zum Zitat Morton DL, Hoon DA, Cochran AJ et al (2003) Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma. Ann Surg 238(4):538–550PubMedPubMedCentral Morton DL, Hoon DA, Cochran AJ et al (2003) Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma. Ann Surg 238(4):538–550PubMedPubMedCentral
9.
Zurück zum Zitat Hirakawa S, Brown LF, Kodama S et al (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109:1010–1017CrossRef Hirakawa S, Brown LF, Kodama S et al (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109:1010–1017CrossRef
10.
Zurück zum Zitat Karaman S, Detmar M (2014) Mechanisms of lymphatic metastasis. J Clin Invest 124:922–928CrossRef Karaman S, Detmar M (2014) Mechanisms of lymphatic metastasis. J Clin Invest 124:922–928CrossRef
11.
Zurück zum Zitat Pereira ER, Kedrin D, Seano G et al (2018) Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 359:1403–1407CrossRef Pereira ER, Kedrin D, Seano G et al (2018) Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 359:1403–1407CrossRef
12.
Zurück zum Zitat Brown M, Assen FP, Leithner A et al (2018) Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. Science 359:1408–1411CrossRef Brown M, Assen FP, Leithner A et al (2018) Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. Science 359:1408–1411CrossRef
13.
Zurück zum Zitat Naxerova K, Reiter JG, Brachtel et al (2017) Origins of lymphatic and distant metastases in human colorectal cancer. Science 357:55–60CrossRef Naxerova K, Reiter JG, Brachtel et al (2017) Origins of lymphatic and distant metastases in human colorectal cancer. Science 357:55–60CrossRef
14.
Zurück zum Zitat Steuer CE, Ramalingam SS (2018) Editorial: tumor mutation burden: leading immunotherapy to the era of precision medicine? J Clin Oncol 36(7):631–632CrossRef Steuer CE, Ramalingam SS (2018) Editorial: tumor mutation burden: leading immunotherapy to the era of precision medicine? J Clin Oncol 36(7):631–632CrossRef
15.
Zurück zum Zitat Rizvi H, Sanchez-Vega F, La K et al (2018) Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing. J Clin Oncol 36(7):633–641CrossRef Rizvi H, Sanchez-Vega F, La K et al (2018) Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing. J Clin Oncol 36(7):633–641CrossRef
18.
Zurück zum Zitat Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252–264CrossRef Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252–264CrossRef
19.
Zurück zum Zitat Darwin C (1859) The origin of species. John Murray, London Darwin C (1859) The origin of species. John Murray, London
20.
Zurück zum Zitat Patel VL, Shortiffe EH, Stefanelli M et al (2009) The coming of age of artificial intelligence in medicine. Artif Intell Med 46(1):5–17CrossRef Patel VL, Shortiffe EH, Stefanelli M et al (2009) The coming of age of artificial intelligence in medicine. Artif Intell Med 46(1):5–17CrossRef
21.
Zurück zum Zitat Al-shamasneh ARM, Obaidellah UJB (2017) Artificial intelligence techniques for cancer detection and classification: review study. Eur Sci J 13(2):342–370 Al-shamasneh ARM, Obaidellah UJB (2017) Artificial intelligence techniques for cancer detection and classification: review study. Eur Sci J 13(2):342–370
Metadaten
Titel
Future perspectives: cancer metastases
verfasst von
Stanley P. Leong
Jonathan S. Zager
Publikationsdatum
23.07.2018
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 5-6/2018
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-018-9920-z

Weitere Artikel der Ausgabe 5-6/2018

Clinical & Experimental Metastasis 5-6/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.